148 related articles for article (PubMed ID: 28431161)
1. Engineering a high-affinity peptide binding site into the anti-CEA mAb M5A.
Zer C; Avery KN; Meyer K; Goodstein L; Bzymek KP; Singh G; Williams JC
Protein Eng Des Sel; 2017 Jun; 30(6):409-417. PubMed ID: 28431161
[TBL] [Abstract][Full Text] [Related]
2. Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies.
Donaldson JM; Zer C; Avery KN; Bzymek KP; Horne DA; Williams JC
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17456-61. PubMed ID: 24101516
[TBL] [Abstract][Full Text] [Related]
3. Refining the Quality of Monoclonal Antibodies: Grafting Unique Peptide-Binding Site in the Fab Framework.
King JD; Williams JC
Methods Mol Biol; 2019; 1904():293-298. PubMed ID: 30539475
[TBL] [Abstract][Full Text] [Related]
4. Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes.
Bzymek KP; Avery KA; Ma Y; Horne DA; Williams JC
Acta Crystallogr F Struct Biol Commun; 2016 Nov; 72(Pt 11):820-830. PubMed ID: 27834791
[TBL] [Abstract][Full Text] [Related]
5. Development of a high affinity, non-covalent biologic to add functionality to Fabs.
Avery KN; Zer C; Bzymek KP; Williams JC
Sci Rep; 2015 Jan; 5():7817. PubMed ID: 25588710
[TBL] [Abstract][Full Text] [Related]
6. Meditope-Fab interaction: threading the hole.
Bzymek KP; Ma Y; Avery KN; Horne DA; Williams JC
Acta Crystallogr F Struct Biol Commun; 2017 Dec; 73(Pt 12):688-694. PubMed ID: 29199990
[TBL] [Abstract][Full Text] [Related]
7. Cyclization strategies of meditopes: affinity and diffraction studies of meditope-Fab complexes.
Bzymek KP; Ma Y; Avery KA; Horne DA; Williams JC
Acta Crystallogr F Struct Biol Commun; 2016 Jun; 72(Pt 6):434-42. PubMed ID: 27303895
[TBL] [Abstract][Full Text] [Related]
8. Humanization of the anti-CEA T84.66 antibody based on crystal structure data.
Yazaki PJ; Sherman MA; Shively JE; Ikle D; Williams LE; Wong JY; Colcher D; Wu AM; Raubitschek AA
Protein Eng Des Sel; 2004 May; 17(5):481-9. PubMed ID: 15316127
[TBL] [Abstract][Full Text] [Related]
9. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
[TBL] [Abstract][Full Text] [Related]
10. Reactivities of an anti-CEA peptide monoclonal antibody.
Horan Hand P; Simpson JF; Kuroki M; Parker R; Schlom J
Int J Biol Markers; 1992; 7(1):1-15. PubMed ID: 1374782
[TBL] [Abstract][Full Text] [Related]
11. Grafting of material-binding function into antibodies Functionalization by peptide grafting.
Hattori T; Umetsu M; Nakanishi T; Tsumoto K; Ohara S; Abe H; Naito M; Asano R; Adschiri T; Kumagai I
Biochem Biophys Res Commun; 2008 Jan; 365(4):751-7. PubMed ID: 18039464
[TBL] [Abstract][Full Text] [Related]
12. The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen.
Tsujisaki M; Hinoda Y; Tokuchi S; Hanzawa Y; Arimura Y; Masuya J; Kitagawa H; Okochi E; Shimamura T; Hamuro J
J Immunol; 1993 Jan; 150(2):508-16. PubMed ID: 8419483
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody therapeutics with up to five specificities: functional enhancement through fusion of target-specific peptides.
LaFleur DW; Abramyan D; Kanakaraj P; Smith RG; Shah RR; Wang G; Yao XT; Kankanala S; Boyd E; Zaritskaya L; Nam V; Puffer BA; Buasen P; Kaithamana S; Burnette AF; Krishnamurthy R; Patel D; Roschke VV; Kiener PA; Hilbert DM; Barbas CF
MAbs; 2013; 5(2):208-18. PubMed ID: 23575268
[TBL] [Abstract][Full Text] [Related]
14. Interaction analysis of the carcinoembryonic antigen (CEA) with its monoclonal antibody immobilized on a gold surface using Fourier transform infrared reflection-absorption spectroscopy (FT-IR RAS).
Ohtsuka K; Kuroki M; Nojima T; Waki M; Takenaka S
Anal Sci; 2005 Mar; 21(3):215-8. PubMed ID: 15790101
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice.
Nittka S; Krueger MA; Shively JE; Boll H; Brockmann MA; Doyon F; Pichler BJ; Neumaier M
PLoS One; 2014; 9(9):e106921. PubMed ID: 25226518
[TBL] [Abstract][Full Text] [Related]
16. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the energetics of an antibody-antigen interface by alanine shaving and molecular grafting.
Jin L; Wells JA
Protein Sci; 1994 Dec; 3(12):2351-7. PubMed ID: 7538848
[TBL] [Abstract][Full Text] [Related]
18. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs.
Hefta LJ; Neumaier M; Shively JE
Immunotechnology; 1998 Jun; 4(1):49-57. PubMed ID: 9661814
[TBL] [Abstract][Full Text] [Related]
20. Internal image-bearing anti-idiotypic monoclonal antibodies.
Hinoda Y; Tsujisaki M; Imai K; Yachi A
Tumour Biol; 1995; 16(1):48-55. PubMed ID: 7863222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
